Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8178.26%
operating margin TTM
-7940.85%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -0.00 |
| peg ratio | -0.00 |
| price to book ratio | 0.00 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -0.20 |
| price fair value | 0.00 |
profitability ratios | |
|---|---|
| gross profit margin | -113.59% |
| operating profit margin | -7940.85% |
| pretax profit margin | -8178.26% |
| net profit margin | -8178.26% |
| return on assets | -180.08% |
| return on equity | -580.57% |
| return on capital employed | -428.58% |
liquidity ratios | |
|---|---|
| current ratio | 1.43 |
| quick ratio | 1.43 |
| cash ratio | 1.30 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 877.67 |
| cash conversion cycle | -877.67 |
| receivables turnover | 0.00 |
| payables turnover | 0.42 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.43 |
| debt equity ratio | 2.05 |
| long term debt to capitalization | 0.34 |
| total debt to capitalization | 0.67 |
| interest coverage | -30.89 |
| cash flow to debt ratio | -3.55 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.87 |
| cash per share | 0.92 |
| operating cash flow per share | -1.84 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -3.55 |
| short term coverage ratios | -4.78 |
| capital expenditure coverage ratio | -68.29 |
Frequently Asked Questions
When was the last time Kaleido Biosciences, Inc. (PNK:KLDO) reported earnings?
Kaleido Biosciences, Inc. (KLDO) published its most recent earnings results on 30-09-2023.
What is Kaleido Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Kaleido Biosciences, Inc. (PNK:KLDO)'s trailing twelve months ROE is -580.57%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Kaleido Biosciences, Inc. (KLDO) currently has a ROA of -180.08%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did KLDO's net profit margin stand at?
KLDO reported a profit margin of -8178.26% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is KLDO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.43 in the most recent quarter. The quick ratio stood at 1.43, with a Debt/Eq ratio of 2.05.